Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada.
$0.88-5.72%
报价 2026-11-06
市值
$123.6M
EV
–
PE (TTM)
2.6x
预期 PE
–
52 周区间距高点 -58.5%
$0.87$2.11
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Drug Manufacturers - Specialty & Generic| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| OGIOrganigram Global Inc. | $123.6M | -5.7% | – | 39.2% | 2.6x | – | – | |
| LFCRLifecore Biomedical, Inc. | $241.1M | -0.6% | +62.7% | 29.7% | – | – | – | |
| SIGASIGA Technologies, Inc. | $222.7M | +4.4% | -32.0% | – | – | – | – | |
| DERMJourney Medical Corporation | $126.2M | +4.0% | +31.1% | 68.4% | – | – | – | |
| CRDLCardiol Therapeutics Inc. | $120.1M | +7.4% | – | 0% | – | – | – | |
| BGMBGM Group Ltd. | $104.7M | -7.3% | – | 12.8% | – | – | 81.1x | |
| ORGOOrganogenesis Holdings Inc. | $104.6M | -3.2% | -44.9% | 67.6% | – | – | 5.2x | |
| CPIXCumberland Pharmaceuticals Inc. | $78.2M | +4.2% | -14.9% | 83.4% | – | – | – | |
| ZYBTZhengye Biotechnology Holding Limited | $71.1M | +8.7% | – | 8.3% | – | – | 14.0x | |
| 同行中位数 | – | – | -14.9% | 29.7% | – | – | 14.0x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
报告货币 CAD（非美元）| Metric | 2026-06-30 Q3 2026 | 2026-03-31 Q2 2026 | 2025-12-31 Q1 2026 | 2025-09-30 Q4 2025 | 2025-06-30 Q3 2025 | 2025-03-31 Q2 2025 | 2024-12-31 Q1 2025 | 2024-09-30 Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | CAD 105.8M | CAD 59.8M | CAD 63.5M | CAD 80.1M | CAD 70.8M | CAD 65.6M | CAD 42.7M | CAD 44.7M |
| Gross Margin | 39.2% | 27.4% | 36.7% | 39.8% | 36.9% | 28.1% | 32.3% | 38.5% |
| Operating Margin | 5% | -16.4% | -5.4% | 1.5% | -3% | -11.6% | -15.9% | 0.6% |
| Net Income | CAD 105.5M | CAD -921,000 | CAD 20M | CAD -38M | CAD -6.3M | CAD 42.5M | CAD -23M | CAD -5.4M |
| Diluted EPS | 0.77 | -0.01 | 0.15 | -0.28 | -0.05 | 0.32 | -0.2 | -0.08 |
| Operating Cash Flow | CAD -4.3M | CAD -6.8M | CAD -16M | CAD -1.5M | CAD 14.6M | CAD -16.6M | CAD -4.2M | CAD 8.9M |
研究材料
Filing 摘要
电话会纪要摘要
暂无纪要摘要。